Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  MAGE-A3 peptide vaccine
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Vaccine Therapy with or without Resiquimod Topical Gel in Treating Patients with Stage IIB-IV Melanoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2008-0416, NCI-2011-02363, NCT00960752
Vaccine Therapy in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
Phase: Phase II
Type: Treatment
Age: 18 to 80
Trial IDs: UPCC 02710, NCI-2011-02934, NCT01245673
Start Over